HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Maurizio DiLiberto Selected Research

Cyclin D1

12/2019A phase I trial of palbociclib plus bortezomib in previously treated mantle cell lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Maurizio DiLiberto Research Topics

Disease

3Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
12/2019 - 03/2016
1Disease Progression
03/2016
1Multiple Myeloma
07/2005
1Testicular Neoplasms (Testicular Cancer)
07/2005
1Monoclonal Gammopathy of Undetermined Significance
07/2005
1Melanoma (Melanoma, Malignant)
07/2005

Drug/Important Bio-Agent (IBA)

2palbociclibIBA
12/2019 - 01/2019
2ibrutinibIBA
01/2019 - 03/2016
1Proteasome InhibitorsIBA
12/2019
1Bortezomib (Velcade)FDA Link
12/2019
1Cyclin D1IBA
12/2019
1Messenger RNA (mRNA)IBA
07/2005
1VaccinesIBA
07/2005
1AntigensIBA
07/2005

Therapy/Procedure

1Immunotherapy
07/2005